PBSS Del Mar October 1 - October 1

This workshop brings together industry experts and FDA perspectives to examine the key preclinical, bioanalytical, regulatory, and development considerations for successful IND filings for antibody-based therapeutics. Discussions will cover antibodies, antibody-drug conjugates, and multispecific antibodies, with topics ranging from pharmacology, PK/PD, bioanalysis, and toxicology to CMC activities, clinical development…